Wells Fargo & Company »

Odyssey Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $34k 1.8k 18.71

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Odyssey Therapeutics

FMR
Sr One Capital Management
Tpg Gp A
Lightspeed Management Company
OrbiMed Advisors
Sanofi
Deerfield Management Company
Sands Capital Ventures
Hillhouse Capital Advisors
General Catalyst Group Management
Affinity Asset Advisors
Adage Capital Partners GP
Vanguard Capital Management
Foresite Capital Management V
Vivo Capital

View all funds holding Odyssey Therapeutics